BALYASNY ASSET MANAGEMENT L.P. - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 70 filers reported holding AC IMMUNE SA in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2022$82,000
-98.3%
25,841
-96.5%
0.00%
-100.0%
Q3 2021$4,920,000
+137.8%
733,180
+181.1%
0.02%
+100.0%
Q2 2021$2,069,000
+944.9%
260,856
+901.1%
0.01%
+900.0%
Q1 2021$198,000
-31.0%
26,058
-22.6%
0.00%
-50.0%
Q4 2019$287,000
-72.4%
33,653
-69.4%
0.00%
-71.4%
Q4 2018$1,040,000
-76.2%
110,000
-79.9%
0.01%
-65.0%
Q3 2018$4,376,000
+1700.8%
547,054
+1995.9%
0.02%
+1900.0%
Q2 2018$243,00026,1010.00%
Other shareholders
AC IMMUNE SA shareholders Q3 2021
NameSharesValueWeighting ↓
Duquesne Family Office 1,500,000$24,705,0002.18%
Monashee Investment Management LLC 275,000$4,529,0001.59%
SPHERA FUNDS MANAGEMENT LTD. 79,800$1,314,0000.21%
Hillhouse Capital Management 550,000$9,059,0000.18%
Temasek Holdings (Private) Ltd 1,337,500$22,029,0000.18%
PointState Capital LP 425,000$7,000,0000.07%
Artal Group S.A. 150,000$2,471,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 87,900$1,448,0000.04%
Schonfeld Strategic Advisors LLC 14,779$243,0000.04%
Point72 Hong Kong Ltd 4,000$66,0000.04%
View complete list of AC IMMUNE SA shareholders